Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB

Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2

(2015) Takayuki Nakagawa et al.   ARCHIVES OF ORAL BIOLOGY

Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs

(2015) M. Motiur Rahman et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vascular Alterations in the Sprague-Dawley Rat Mandible During Intravenous Bisphosphonate Therapy

(2015) Chestine S. Guevarra et al.   Journal of Oral Implantology

Effect of Denosumab on Recurrent Giant Cell Reparative Granuloma of the Lumbar Spine

(2015) Koji Akeda et al.   SPINE

Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation

(2015) Han-Ching Tseng et al.   Oncotarget

Alternative Pharmacologic Therapy for Aggressive Central Giant Cell Granuloma: Denosumab

(2014) Willem H. Schreuder et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone

(2014) Anjali P. Kusumbe et al.   NATURE

PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis

(2014) Hui Xie et al.   NATURE MEDICINE

Bisphosphonates’ antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay

(2013) A. M. Pabst et al.   Clinical Oral Investigations

Zoledronic Acid Inhibits Human Osteoblast Activities

(2013) Fernanda G. Basso et al.   GERONTOLOGY

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid

(2012) Gabriella Misso et al.   CANCER BIOLOGY & THERAPY

Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival

(2012) Hyung Joon Kim et al.   JOURNAL OF CELL BIOLOGY

Zoledronate Attenuates Angiogenic Effects of Angiotensin II-Stimulated Endothelial Progenitor Cells via RhoA and MAPK Signaling

(2012) Jin-Xiu Yang et al.   PLoS One

Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells

(2011) Jillian Cornish et al.   BONE

Bisphosphonates: The first 40years

(2011) R. Graham G. Russell   BONE

Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts

(2011) Joo-Young Ohe et al.   Clinical Oral Investigations

Pharmacokinetic evaluation of zoledronic acid

(2011) Antonella De Luca et al.   Expert Opinion on Drug Metabolism & Toxicology

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone

(2010) Heng Zhu et al.   Nature Protocols